Molleave — Class II drug recall D-0622-2018
Terminated recall by Elroselabs Inc., reported 2018-04-18, distributed nationwide. cGMP Deviations
| Recall number | D-0622-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Elroselabs Inc., Sanford, FL, United States |
| Recall initiated | 2018-03-28 |
| Classified | 2018-04-06 |
| Reported by FDA | 2018-04-18 |
| Terminated | 2020-12-15 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
Product
Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.
Reason for recall
cGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0622-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.